Abstract: ObjectiveObserve the safety and efficacy of combined treatment of sixingredient rehmannia pill for childhood bronchial asthma.
MethodsA total of 50 children definitely diagnosed with asthma were randomly divided into two groups,25 in the combined group and 25 children in the control group.The combined group was treated with corticosteroids combined with sixingredient rehmannia pill.The control group was treated with corticosteroids alone.The safety and efficacy of the two groups were closely observed.
ResultsAfter the treatment,the PEFR average point in the combined group was (200.33±28.11)L/s,which was higher than that in the control group (180.12±20.31)L/s,the difference having statistical significance.During the oneyear treatment,the average number of acute attack of asthma in the combined group and the control group was 0.69±0.62 and 1.34±0.42,respectively,which had statistical significance(P<0.05).As for the hospitalization of acute attack of asthma,the average number was 0.07±0.23 and 0.15±0.32,respectively,which had statistical significance(P<0.05).Respectively 25 children in the combined group and 19 children in the control group reached the normal expected PEFR number,which had statistical significance(P<0.05).
ConclusionsThe curative effect of the combined application of sixingredient rehmannia pill for childhood bronchial asthma is significantly better than pure western medicine therapy.

Key words: Asthma/TCM therapy, Sixingredient rehmannia pill/therapeutic, Peak expiratory flow, Child